BPA Call 36C24121A0025-36C24126N0274
- Not listed
- On November 1, 2019, the Veterans Integrated Service Network 1 (VISN 1), a regional network within the Department of Veterans Affairs, awarded a purchase order valued at $470,781 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the procurement of radiopharmaceuticals. The contract, structured as a firm fixed-price purchase order with no set-aside designation, is scheduled for completion by December 31, 2025, and covers the supply and delivery of...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $598,140.00 Blanket Purchase Agreement (BPA) Call contract is for the supply of radiopharmaceuticals, including Ga-68 Dotatate, gallium-based imaging agents, iodine I-123, and therapeutic radioisotopes used in nuclear medicine procedures such as PET scans, cardiac imaging, and cancer treatment. The contract has a performance...
- The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 10 (VISN 10), awarded a $75,228.11 firm fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on December 18, 2025, for the supply of nuclear medicine radiopharmaceuticals. The contract, which carries an ultimate completion date of December 17, 2028, represents a delivery order under a larger indefinite delivery vehicle established between the VA and Jubilant...
- The Department of Veterans Affairs (VA) awarded a firm-fixed-price Blanket Purchase Agreement (BPA) contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The $6.6 million contract, awarded through VA Veterans Integrated Service Network 1, is for the supply of radiopharmaceuticals and nuclear medicine products, including specialized isotopes and imaging agents used in diagnostic procedures and cancer...
- The Department of Veterans Affairs Veterans Integrated Service Network 4 (VISN 4) awarded a $132,000 firm fixed-price blanket purchase agreement (BPA) call to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the supply of Ioflupane radiopharmaceutical products. The award, issued on January 17, 2026, with an ultimate completion date of January 16, 2027, will support nuclear medicine diagnostic imaging procedures at VA medical facilities in the Philadelphia,...
- This federal contract, valued at $439,477.00, was awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business. The contract, awarded by the Department of Veterans Affairs (VA) through its Veterans Integrated Service Network (VISN) 15, is for the supply of radiopharmaceuticals, including medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $93,446.62 firm fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. This contract is to provide radiopharmaceuticals supporting nuclear medicine services and procedures for veterans at VA medical facilities. Jubilant Radiopharma has held multiple indefinite delivery contracts and blanket purchase...
- This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business that specializes in manufacturing and supplying radiopharmaceuticals and nuclear medicine products. The contract, valued at $122,387.32, is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) for the provision of radiopharmaceuticals such as Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical...
- The Department of Veterans Affairs (VA) has awarded a $499,491.56 firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. This contract, awarded under VA Veterans Integrated Service Network 6 (VISN 6), has an ultimate completion date of March 4, 2025. Jubilant Radiopharma, a subsidiary of Jubilant Life Sciences Limited, is a key supplier...
- 36C24121A0025Blanket Purchase Agreement
- 36C24121A0025-36C24126N0274BPA Call
This contract award is a Blanket Purchase Agreement (BPA) call issued by Veterans Integrated Service Network (VISN) 1, a regional healthcare network within the Department of Veterans Affairs, to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the supply of radiopharmaceuticals. The order, valued at $771,410.67 with a firm fixed price structure, was awarded on January 30, 2026, and is scheduled for completion by January 29, 2027. The work will be performed in West Roxbury, Massachusetts, and no set-aside designation was used for this procurement. Jubilant Radiopharma, a small disadvantaged business subsidiary of Jubilant Life Sciences Limited, specializes in manufacturing and distributing nuclear medicine products and medical isotopes essential for diagnostic imaging and cancer treatment procedures across the VA healthcare system. This BPA call is part of a larger indefinite delivery vehicle that enables VISN 1 and other regional VA networks to efficiently procure critical radiopharmaceutical products, including specialized isotopes such as Gallium 68 Dotatate, iodine I-123, and technetium-99m used in PET scans, cardiac imaging, and diagnostic procedures. Jubilant Radiopharma has demonstrated substantial capacity and experience serving multiple VA networks and the Defense Health Agency through numerous prior contract awards, with existing IDV relationships ranging up to $39.8 million in potential value. This particular award reflects the vendor's ongoing role as a key supplier of nuclear medicine products supporting healthcare services for veterans across VISN 1 facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $771.4k | 1/30/26 |